Study of 3D189 in Patients With Hematologic Malignancies (opens ClinicalTrials.gov)
- Sponsor
- 3D Medicines
- Enrolment
- 16
- Started
- 2022-08-01
- Last update
- 2026-09-09
Conditions: Acute Leukemia, Multiple Myeloma, Non-Hodgkin Lymphoma, Higher-risk Myelodysplastic Syndrome
Interventions: 3D189